Recent Posts

Growth is Rising, but Profits are Flat: The Hidden Cost of Disconnected Commercial Teams

Ben Keswani · June 5, 2026

June 5, 2026

Growth is Rising, but Profits are Flat: The Hidden Cost of Disconnected Commercial Teams

In the MedTech sector, a paradox has emerged as we move through

May 20, 2026

For the Record with Nicholas P Rennich, Vice President, MTE Solutions

1) What is MTE Solutions? MTE Solutions is a trusted supply‑chain partner

May 20, 2026

For the Record with Bill Jacqmein, CEO, Prime Path Medtech

1) What is Prime Path MedTech? Prime Path Medtech is a Medical

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel), a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma

Tyler Mason

February 9, 2021

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel), a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma

PhysIQ and U.S. Veteran’s Affairs Advance to Interventional Trial Phase

Tyler Mason

February 9, 2021

PhysIQ and U.S. Veteran’s Affairs Advance to Interventional Trial Phase

In The Know: Healthcare News for February 8, 2021

Katie Lew

February 8, 2021

In The Know: Healthcare News for February 8, 2021

Medtech Innovation & Adaptation: Insights with Boston Scientific’s David Knapp

Katie Lew

February 7, 2021

Medtech Innovation & Adaptation: Insights with Boston Scientific’s David Knapp

Learn more about [your subject]. Start Now!

Click the button to get started!

Success message!

Warning message!

Error message!